Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in
Pre-market
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverXTNT
HealthcareASEUSD

Xtant Medical Holdings, Inc.

$00123456789.0012345678900123456789-1.6%
52w low $0.27$0.95 52w high
Market data · updated 5h ago
Market data
Market cap
$60.13M
52w range
$0.27 - $0.95
Sector
Healthcare
Data quality
92/100
Valuation
P/E ratio
42.9x
fair value estimate
$0.35
Margin of safety
-1.2%
PEG ratio
1.74
Quality & efficiency
Moat score
39/100
Return on equity
3.9%
Profit margin
1.5%
Debt / equity
0.32
Growth & analysts
Revenue growth
-36.5%
Analyst target
$1.35
Target upside
+281.1%
Analysts
2
Run the 10-point checklist before you buy How these numbers are made

About Xtant Medical Holdings, Inc.

Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor Pro, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers cervical products comprising Spider cervical plating, Streamline OCT system, and CervAlign systems; thoracolumbar products, such as of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; Silex sacroiliac joint fusion systems; interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; Contact ALP (Anterior Lumbar Plate) System; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain. The company is headquartered in Belgrade, Montana.

Valuation

ValueGrowthProfitHealthIncome31QUALITY
Overall Rating
30
Low quality
Low quality

Derived from filed metrics · High confidence (92% of the inputs available)

Moat Score39
Fair value estimate
$0.35-1.2% downside

Moat, fair value and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
$60.13M
P/E Ratio
42.9
Dividend Yield
0.00%
Revenue Growth
-36.5%
Profit Margin
1.5%
ROE
3.9%
Debt / Equity
0.32
Beta
-0.16
Beaten Down

Statistics

Similar Stocks · Healthcare

Latest News · XTNT